Skip to content

Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study

Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01465620
Enrollment
8
Registered
2011-11-07
Start date
2011-11-30
Completion date
2018-06-30
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Polyneuropathy, Metabolic Syndrome X, Peripheral Nervous System Diseases

Keywords

Peripheral Nervous System Diseases, Diabetic Polyneuropathy, Metabolic Syndrome X

Brief summary

Metabolic disorders such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. To investigate the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters of patients with metabolic neuropathies.

Detailed description

Metabolic disorder such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. The objectives of the present study are to investigate: 1. the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters 2. the best coaching modality of education. This will be a prospective single blind study (blinded evaluator). Patients will be randomly assigned in two groups. The first group will have a one-day therapeutic education program followed by a 5-minutes phone call every week for 3 months. The second group will have the same one-day therapeutic education program that will be followed by an unique one-hour phone call. During the one-day therapeutic education program and the phone calls, hygienic rules (ie physical activities) and dietetic regimen advices will be given to patients. Evaluation will be done at 3 months.

Interventions

BEHAVIORALhygienic-dietetic measures

Therapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months

Sponsors

Henri Mondor University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical and neurophysiologic neuropathy (clinical signs of neuropathy and at least two low sensory nerve action potential (superficial peroneal and sural nerves)) * Metabolic disorder: Glucose disorder (diabetes mellitus or glucose intolerance) or metabolic syndrome * Clinical signs for less than 2 years * No therapeutic modification in the last 3 months * Possibility to delay any drug modification during 3 months

Exclusion criteria

* Non metabolic neuropathy * Serious diabetic complication * Renal failure (creatinine clearance\<60ml/min) * Sensory neuronopathy * Contra-indication to physical activity * Type 1 diabetes mellitus * No written consent

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in NTSS6 score at 3 months3 monthsChange from Baseline in NTSS6 score at 3 months (Bastyr EJ, 3rd, Price KL, Bril V. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther. 2005 Aug;27(8):1278-94)

Secondary

MeasureTime frameDescription
clinical global impression of change3 months
change from baseline of sensory nerve action potential and sensory and motor nerve velocity3 monthschange from baseline of sensory nerve action potential and sensory and motor nerve velocity at 3 months
change from baseline of thermal and vibration thresholds3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026